US · Basic Materials · Specialty Chemicals
EPS came in at 1.12 against a street estimate of 1.30 — a miss of 13.8%.
Analysts rate Ashland Global Holdings Inc a buy (9 buy, 3 hold, 0 sell out of 12) with an average price target of $80.45.
CONFIDENT Q3 delivered 7% sales growth across all units; Life Sciences +11%, Personal Care +5%, Specialty Additives +4%. Operating challenges persist but pricing gaining traction. Net leverage improved to 2.4x target. Reaffirmed FY26 guidance; raised board diversity. Q3 FY26 Personal Care Americas/China led growth. Specialty Additives saw broad improvement except Europe (Germany/France weakness). Middle East/Africa/India outperformed despite challenges. Analysts pressed on pricing sustainability/flow-through (management confident), manufacturing optimization timeline (cautiously optimistic on gradual Q4 improvement), and activist/sale process (management will not speculate; board refocused on execution). Management emphasized operational improvements take quarters to flow through P&L; emphasized value-based pricing, not margin expansion. 2026-07-29…
Full summary in the app.
| Fund | Stake |
|---|---|
| BlackRock Inc | 12.47% |
| 40 North Industries LLC | 9.88% |
| Franklin Templeton Inc | 7.90% |
| Dimensional Fund Advisors, Inc. | 5.43% |
| Vanguard Portfolio Management, LLC | 5.38% |
| Vanguard Capital Management, LLC | 4.51% |
| Massachusetts Financial Services Company | 4.45% |
| Frontier Capital Management CO Inc | 4.37% |
| Document | Date |
|---|---|
| Results announced · Q1 FY2027 HEADLINE NUMBERS • Fourth-quarter fiscal 2026 sales were $498 million, up four percent from $478 million a year earlier. Sales volumes rose three per | 2026-11-03 |
| Material agreement · Q4 FY2026 ASHLAND INC. - 8-K SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Facility Size: €125 million aggregate limit for European accounts receivable secu | 2026-09-25 |
| Material agreement · Q4 FY2026 ASHLAND INC. - 8-K SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Accounts Receivable Securitization Facility: $70 million in commitments • Facilit | 2026-07-31 |
| Quarterly report · Q3 FY2026 ASHLAND INC. - 10-Q SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Q3 2026 (three months ended June 30): Sales $497 million vs. $463 million prior | 2026-07-29 |
| Material agreement · Q4 FY2026 ASHLAND INC. (ASH) - 8-K FILING SUMMARY July 27, 2026 --- HEADLINE NUMBERS • Board size increased to 11 members (from prior size), with plan to red | 2026-07-28 |
| Results announced · Q4 FY2026 ASHLAND INC. Q3 FISCAL 2026 RESULTS SUMMARY HEADLINE NUMBERS • Sales: $497 million, up 7% year-over-year ($463 million in prior year) • Income from | 2026-07-28 |
| Material agreement · Q3 FY2026 ASHLAND INC. - 8-K FILING SUMMARY (May 28, 2026) HEADLINE NUMBERS • $500 million five-year revolving credit facility established under new Credit Ag | 2026-05-29 |
| Quarterly report · Q2 FY2026 ASHLAND INC. – FORM 10-Q SUMMARY Quarter Ended March 31, 2026 --- HEADLINE NUMBERS • Q1 FY2026 Sales: $482 million (Q1 FY2025: $479 million) – up $ | 2026-04-29 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | $0.42 / share ex-date Sep 1, 2026 · pay Sep 15, 2026 | 2026-09-01 |
| Dividend | $0.42 / share ex-date Jun 1, 2026 · pay Jun 15, 2026 | 2026-06-01 |
| Dividend | $0.41 / share ex-date Feb 27, 2026 · pay Mar 15, 2026 | 2026-02-27 |
| Dividend | $0.41 / share ex-date Dec 1, 2025 · pay Dec 15, 2025 | 2025-12-01 |
| Announcement | Date |
|---|---|
| Fiscal 2027 sales and adjusted EBITDA outlook issued Ashland reported a mixed but generally improved fourth quarter of fiscal 2026. Sales rose 4% year over year to $498 million, helped by 3% higher volumes and 2% pricing, although foreign exch | 2026-11-03 |
| Q2 FY2026 results; full-year sales and EBITDA guidance updated Ashland Inc., a specialty chemicals company, reported Q2 fiscal 2026 results with mixed performance. Sales reached $482 million, up just 1% year-over-year, while adjusted EBITDA declined 9% | 2026-04-28 |
| Narrowed full-year fiscal 2026 Adjusted EBITDA guidance to $400-$420 million Ashland Inc., a specialty chemicals company, reported Q1 fiscal 2026 results showing modest decline but maintained profitability through cost management. Sales fell 5% to $386 million (3% ex | 2026-02-02 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Ashland Global Holdings Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.